Trademark Details For DMP (Serial Number 73823354)

  •  Home
  •  Print
DMP
0
0
0
0
Basic Information
Serial Number  United States - USPTO 73823354
Registration Number 1606863
Mark
DMP
Filing Date Sep-05-1989
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0


  • DURALINE MEDICAL PRODUCTS, INC.


042Computer, scientific and legal

U.S Class(es): 101

Class Status: Active

First Use: Nov-15-1985

First Use in Commerce: Nov-15-1985


26.03.01



Correspondences

NameChris L. Bollinger
AddressSchiff Hardin LLP PO BOX 06079 CHICAGO IL 60606-0079

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Nov-15-1989ASSIGNED TO EXAMINER   DOCKD
Dec-07-1989NON-FINAL ACTION MAILED   CNRTF
Jan-02-1990CORRESPONDENCE RECEIVED IN LAW OFFICE   CRFAI
Jan-23-1990APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Mar-24-1990NOTICE OF PUBLICATION   NPUBO
Apr-24-1990PUBLISHED FOR OPPOSITION   PUBOA
Jul-17-1990REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-06-1995REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED   815FI
Jun-13-1996REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Dec-27-1999REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED   89AFI
Aug-30-2000REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Aug-30-2000REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Sep-23-2003TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Dec-24-2008CASE FILE IN TICRS   CFITO
Jul-19-2010TEAS SECTION 8 & 9 RECEIVED   E89RI
Jul-27-2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jul-28-2010REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jul-28-2010REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)   RNL2Q
Jul-01-2020TEAS SECTION 8 & 9 RECEIVED   E89RI
Aug-18-2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Aug-20-2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Aug-20-2020REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)   RNL3Q
Aug-20-2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E